A股異動丨華星創業一度拉昇升近7%
格隆匯5月10日丨AI+IP概念股華星創業(300025.SZ)早盤拉昇,最高升近7%報10.10元。據悉,華星創業是國內唯一一家拿到三體宇宙三項《三體》IP授權的A股上市企業,其中包括MR內容開發和MR設備。另悉,蘋果WWDC在即,MR有望首亮相。興證電子稱,自2016年發佈AirPods至今,蘋果已經七年未發重點新單品,MR預計將是消費電子下一波主線,今年6月5日WWDC上MR有可能將首次亮相。隨着MR發佈在即,蘋果MR產業鏈情緒預計將進一步催化,可重點關注。華星亦為MR概念股而獲得市場追捧。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.